CPH 0.00% 0.9¢ creso pharma limited

I agree. The merger with PCLO significantly de-risks the...

  1. 46 Posts.
    lightbulb Created with Sketch. 24
    I agree. The merger with PCLO significantly de-risks the outlook; larger players have a higher survival rate. The methodical approach they both share and the explosion in demand will win out long term, no matter how gradual the beginnings. Take eyes off short term market conniptions and any wild conspiracy theories and watch it grow over time. Green days welcome but not essential at this stage!
 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.